Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial)

EuroIntervention. 2018 Jan 20;13(13):1587-1590. doi: 10.4244/EIJ-D-17-00731.

Authors

Lisette Okkels Jensen¹, Michael Maeng, Bent Raungaard, Knud Nørregaard Hansen, Johnny Kahlert, Svend Eggert Jensen, Henrik Steen Hansen, Jens Flensted Lassen, Hans Erik Bøtker, Evald Høj Christiansen

Affiliation

¹ Department of Cardiology, Odense University Hospital, Odense, Denmark.

PMID: 28870882
DOI: 10.4244/EIJ-D-17-00731

No abstract available

Publication types

Comparative Study
Randomized Controlled Trial

MeSH terms

Absorbable Implants*
Cardiovascular Agents / administration & dosage*
Cardiovascular Agents / adverse effects
Coated Materials, Biocompatible*
Coronary Artery Disease / diagnostic imaging
Coronary Artery Disease / mortality
Coronary Artery Disease / surgery*
Coronary Thrombosis / epidemiology
Drug-Eluting Stents*
Humans
Percutaneous Coronary Intervention / adverse effects
Percutaneous Coronary Intervention / instrumentation*
Percutaneous Coronary Intervention / mortality
Polymers*
Prosthesis Design
Risk Factors
Sirolimus / administration & dosage
Sirolimus / adverse effects
Sirolimus / analogs & derivatives*
Time Factors
Treatment Outcome

Substances

Cardiovascular Agents
Coated Materials, Biocompatible
Polymers
umirolimus
Sirolimus